Kyongbo Pharmaceutical

경보제약KRX: 214390· Fiscal year 2025· kbpharma.co.kr ↗

Average salary
$56.0K
₩74.6M
▲ 3.9% vs 2024
Employees
571
▲ 8.8% vs 2024
Average tenure
Not disclosed

Estimated take-home of this pay:$3.8K / monthCalculate →

Workplace

Women's pay (men = 100)78
Women among staff23.3%
Contract staff2.3%

Recent official filings

Quick read

  • Average pay is 22% above the median of the companies we track.
  • Average pay rose 3.9% from 2024.
  • Headcount grew by 46 (8.8%) from 2024.
  • Ranks #35 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 10.7% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 1.3% in 2025.

Last 3 years

Revenue
$162.4M2023$179.1M2024$198.2M2025
Operating income
$4.2M2023$7.8M2024$2.6M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$346.3K
Net profit per employee
$239
Operating margin
1.3%
Net margin
0.1%
ROE
0.1%
Debt-to-equity
119.3%
Equity ratio
45.6%
Payout ratio
656.6%
Dividend per share
$0
Dividend yield (as disclosed)
0.8%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.